Royal Bank of Canada’s KalVista Pharmaceuticals KALV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$727K Buy
64,294
+64,143
+42,479% +$725K ﹤0.01% 3864
2025
Q1
$2K Sell
151
-548
-78% -$7.26K ﹤0.01% 6185
2024
Q4
$6K Sell
699
-3,294
-82% -$28.3K ﹤0.01% 5999
2024
Q3
$47K Buy
3,993
+411
+11% +$4.84K ﹤0.01% 5264
2024
Q2
$42K Buy
3,582
+2,880
+410% +$33.8K ﹤0.01% 5345
2024
Q1
$8K Sell
702
-9,088
-93% -$104K ﹤0.01% 5834
2023
Q4
$120K Buy
9,790
+5,564
+132% +$68.2K ﹤0.01% 4972
2023
Q3
$41K Sell
4,226
-266
-6% -$2.58K ﹤0.01% 5394
2023
Q2
$40K Buy
4,492
+3,113
+226% +$27.7K ﹤0.01% 5431
2023
Q1
$11K Sell
1,379
-2,953
-68% -$23.6K ﹤0.01% 5877
2022
Q4
$29K Sell
4,332
-5,515
-56% -$36.9K ﹤0.01% 5678
2022
Q3
$143K Buy
9,847
+9,709
+7,036% +$141K ﹤0.01% 4569
2022
Q2
$1K Sell
138
-1,238
-90% -$8.97K ﹤0.01% 6674
2022
Q1
$20K Sell
1,376
-3,595
-72% -$52.3K ﹤0.01% 6119
2021
Q4
$66K Buy
4,971
+2,646
+114% +$35.1K ﹤0.01% 5681
2021
Q3
$41K Sell
2,325
-575
-20% -$10.1K ﹤0.01% 5753
2021
Q2
$70K Buy
2,900
+1,112
+62% +$26.8K ﹤0.01% 5324
2021
Q1
$46K Buy
1,788
+1,118
+167% +$28.8K ﹤0.01% 5440
2020
Q4
$13K Buy
670
+649
+3,090% +$12.6K ﹤0.01% 5707
2020
Q3
$0 Buy
+21
New ﹤0.01% 6233
2020
Q2
Sell
-32
Closed 6217
2020
Q1
$0 Sell
32
-1,231
-97% ﹤0.01% 6231
2019
Q4
$22K Buy
+1,263
New +$22K ﹤0.01% 5217
2018
Q4
Sell
-10
Closed 5953
2018
Q3
$0 Buy
+10
New ﹤0.01% 6175
2017
Q2
Sell
-1
Closed 5861
2017
Q1
$0 Buy
+1
New ﹤0.01% 5938
2016
Q1
Sell
-357
Closed -$18K 5695
2015
Q4
$18K Buy
357
+317
+793% +$16K ﹤0.01% 4993
2015
Q3
$2K Sell
40
-19
-32% -$950 ﹤0.01% 5772
2015
Q2
$6K Buy
+59
New +$6K ﹤0.01% 5703